REGULATORY AGENCY ACTION
awarded the human drug testing contract
to PharmChem Laboratories, which had
submitted the only bid for that contract.
At its September 23 meeting, CHRB
elected Ralph Scurfield to serve as Board
Chair, and Donald Valpredo to serve as
Vice-Chair.

■ FUTURE MEETINGS
January 29 in Monrovia.
February 26 in Arcadia.
March 26 in Berkeley.
April 30 in Arcadia.

NEW MOTOR VEHICLE
BOARD
Executive Officer:
Sam W. Jennings
(916) 445-1888
to Vehicle Code section 3000
Petursuant
seq., the New Motor Vehicle Board
licenses new motor vehicle
(NMVB)

dealerships and regulates dealership
relocations and manufacturer terminations of franchises. It reviews disciplinary
action taken against dealers by the Department of Motor Vehicles (DMV). Most
licensees deal in cars or motorcycles.
NMVB is authorized to adopt regulations to implement its enabling legislation; the Board's regulations are codified
in Chapter 2, Division I, Title 13 of the
California Code of Regulations (CCR).
The Board also handles disputes arising
out of warranty reimbursement schedules.
After servicing or replacing parts in a car
under warranty, a dealer is reimbursed by
the manufacturer. The manufacturer sets
reimbursement rates which a dealer occasionally challenges as unreasonable. Infrequently, the manufacturer's failure to
compensate the dealer for tests performed
on vehicles is questioned.
The Board consists of four dealer
members and five public members. The
Board's staff consists of an executive
secretary, three legal assistants and two
secretaries.

■ MAJOR PROJECTS
Board Permits Termination of
Franchise. At its July 24 meeting, NMVB
considered a protest filed by Jim Lynch
Cadillac, Inc., against General Motors
Corporation's (GMC) Cadillac Motor Car
Division, following GMC's October 1991
decision to terminate the Cadillac
franchise held by Lynch. In considering
the protest, NMVB noted that Vehicle
Code section 3066 imposes upon GMC
the burden of establishing the existence of

good cause to terminate or refuse to continue Lynch's franchise. In determining
whether good cause has been established,
Vehicle Code section 3061 requires
NMVB to consider the amount of business
transacted by the franchisee, as compared
to the business available to the franchisee;
any investment necessarily made and
obligations incurred by the franchisee to
perform its part of the franchise; the permanency of the investment; whether it is
injurious or beneficial to the public welfare for the franchise to be modified or
replaced or the business of the franchisee
disrupted; whether the franchisee has adequate motor vehicle sales and service
facilities, equipment, vehicle parts, and
qualified service personnel to reasonably
provide for the needs of the consumers for
the motor vehicles handled by the
franchisee and has been and is rendering
adequate services to the public; whether
the franchisee has failed to fulfill the warranty obligations of the franchisor to be
performed by the franchisee; and the extent of the franchisee's failure to comply
with the terms of the franchise.
According to GMC, good cause existed to terminate Lynch's franchise because of Lynch's breach of the terms of the
franchise. According to GMC, Lynch
breached its Dealer Agreement by abandoning its sales facility located on La Brea
Avenue in Inglewood, and consolidating
its new car sales operation at an unapproved and unauthorized service location
on Centinela Avenue in Inglewood. Lynch
contended that it had been attempting for
five years to find possible sites for the
relocation of the dealership, and that the
Centinela location was merely a temporary arrangement while it continued to
pursue efforts to relocate. Lynch also contended that the consolidation was justified
because continued operations from both
facilities would have resulted in Lynch's
insolvency.
After reviewing the available data,
NMVB made the following findings:
-In light of the sufficient opportunity
for Cadillac sales within Lynch's area of
geographic sales and service, Lynch has
been "weak and marginal as a Cadillac
dealer."
-Of the $2.775 million acquisition
price, only $ I 60,000 qualifies as Lynch's
permanent investment.
-The public is inconvenienced and
Cadillac's image and standards are
diminished by the fact that there is no
showroom for new vehicles at the Centinela facility; new and used car sales are
conducted out of two mobile home-type
trailers located in the parking lot; the
facility is crowded and new car customers
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must first go through the service area
before they get to the area where the new
cars are located.
-The Centinela facility has only 17.3%
of the space required by GM C's space and
facilities guidelines and is therefore deficient under those guidelines.
-Lynch's decision to consolidate was
precipitated by the expiration of its lease
at the La Brea location and its desire to
reduce its monthly losses.
-Lynch's fiscal condition does not justify an unauthorized relocation of its sales
operations.
Accordingly, NMVB concluded that
Lynch breached its Dealer Agreement by
unilaterally moving its new car sales
operations from the approved location to
an unauthorized location, and to the extent
that the unauthorized relocation resulted
in inadequate facilities which are far
below the facilities and space guidelines
required under the Dealer Agreement. As
a result, NMVB held that GMC is permitted to terminate the franchise of Jim
Lynch Cadillac.
Board Settles Warranty Debate. In
November 1991, Quaid Imports, Inc., a
Maserati franchisee since 1983, filed petition number P-230-91 with NMVB, seeking damages and declaratory relief on its
claim that Maserati Automobiles, Inc.
(Maserati) had refused to reimburse Quaid
for warranty repairs made to a certain
1989 Maserati automobile. Pursuant to an
April 1990 settlement agreement reached
by the parties in an unrelated matter,
Maserati had delivered a new Maserati to
Quaid and agreed that Quaid would retain
"the two new Maserati automobiles curre n ti y in its possession"; the 1989
Maserati at issue in Quaid's November
l 991 petition was one of the "new
Maserati automobiles" referred to in the
Aprill 1990 settlement agreement.
Pursuant to Maserati's Standard
Dealer Agreement, Quaid was required to
maintain at least one demonstrator available at all times. On November 22, 1988,
the date of deli very of the l 989 Maserati,
Quaid informed his inventory manager
that he would use that automobile as his
demonstrator; the manager immediately
filed a Demonstrator Report Card with
Maserati, as required by the Agreement.
Under the terms of Maserati's 1989 model
year warranty, the coverage period could
start either on the date of retail delivery to
a customer or upon first use as a
demonstrator or company car; the total
term of the warranty was three years or
36,000 miles, whichever came first.
Maserati was to administer the coverage
for the first two years or 24,000 miles
directly, and the third year of extended
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coverage was provided through Maryland
Casualty.
Quaid only drove the vehicle once, and
changed his mind about using the car as a
demonstrator; however, he did allow the
car to be test-driven by prospective purchasers. In October 1990, Quaid informed
Maserati that the Demonstrator Report
Card was filed in error and that he had not
actually used the car as a demonstrator. In
March 1991, Quaid discovered that the
car's battery was dead; he replaced the
battery and filed a claim for reimbursement with Maserati. In May 1991,
Maserati rejected the claim, contending
that the vehicle's factory warranty term
had begun to run on November 22, 1988,
and that the two-year factory warranty had
expired. In September 1991, the vehicle
was sold to a customer who was told that
the vehicle was a new vehicle with 340
miles on the odometer. Within a month,
the customer had returned the vehicle for
repairs totalling $499.81; that claim was
also rejected by Maserati, which again
contended that the two-year factory warranty had expired.
Because the April 1990 settlement
agreement in the separate matter referred
to the Maserati in question as "new,"
Quaid contended that the warranty period
on the subject vehicle had not actually
commenced. Because the word "new," as
it appears in the settlement agreement with
reference to the subject vehicle, is
reasonably susceptible to more than one
meaning, NMVB allowed parol evidence
to determine whether the parties intended
that the vehicle would be retained by
Quaid with a full 36-month warranty or
with 28 months of warranty coverage already expired. After reviewing the
evidence presented to it, NMVB concluded that in the context of the settlement
agreement, the word "new" was meant to
designate those vehicles which Quaid
would retain for retail sale to the public; it
did not mean that the status of the subject
vehicle was changed from "demonstrator"
to "new vehicle" for the purpose of warranty. Thus, NMVB concluded that
Maserati's coverage ended on November
22, 1990; any obligation for warranty
claims during the third year of warranty
coverage is the responsibility of Maryland
Casualty.

■ LEGISLATION
AB 126 (Moore) would have enacted
the "One-Day Cancellation Law" which
would have provided that, in addition to
any other right to revoke an offer or rescind a contract, the buyer of a motor
vehicle has the right to cancel a motor
vehicle contract or offer which complies
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with specified requirements until the close
of business of the first business day after
the day on which the buyer signed the
contract or offer. This bill died in committee.

■ FUTURE MEETINGS
To be announced.

OSTEOPATHIC
MEDICAL BOARD OF
CALIFORNIA
Executive Director:
Linda Bergmann
(916) 322-4306
n 1922, California voters approved a
constitutional initiative which created
the Board of Osteopathic Examiners;
199 I legislation changed the Board's
name to the Osteopathic Medical Board of
California (OMBC). Today, pursuant to
Business and Professions Code section
3600 et seq., OMBC regulates entry into
the osteopathic profession, examines and
approves schools and colleges of osteopathic medicine, and enforces professional standards. The Board is empowered
to adopt regulations to implement its enabling legislation; OMBC's regulations are
codified in Division 16, Title 16 of the
California Code of Regulations (CCR).
The 1922 initiative, which provided for a
five-member Board consisting of practicing doctors of osteopathy (DOs), was
amended in 1982 to include two public
members. The Board now consists of
seven members, appointed by the Governor, serving staggered three-year terms.
The Board is presently awaiting
Governor Wilson's appointment of three
new members (two DOs and one public
member).

I

■ MAJOR PROJECTS
Governor Upholds OAL Rejection
of Medical Board's Training Program
Regulation. On June 11, Governor Wilson upheld the Office of Administrative
Law's (OAL) rejection of the Medical
Board of California's (MBC) adoption of
section I 325.5, Division 13, Title 16 of the
CCR, as being discriminatory against osteopathic physicians.
Under regulatory section 1324, MBC's
Division of Licensing (DOL) is
authorized to approve alternative clinical
training programs for foreign medical
graduates who have difficulty obtaining a
postgraduate training program approved
by the Accreditation Council on Graduate
Medical Education of the American Medi-

cal Association. DOL recently adopted
new section 1325.5, which would have
required the medical director of a section
1324 training program to have an MD
degree. The Division insisted on this
provision over numerous objections that it
violates Busi:1ess and Professions Code
section 2453, which prohibits discrimination between MDs and osteopathic
physicians (DOs) on the basis of the degree. OAL rejected the provision three
times, and DOL appealed the rejection to
the Governor shortly after its May 7 meeting. [12:2&3 CRLR 102,256]
On June 11, the Governor upheld
OAL's rejection of the MD requirement,
recognizing the "hundred years war" between the allopathic and osteopathic
branches of the medical profession and
noting that "[t]he California Legislature
has mandated equality between holders of
MD degrees (medical doctors) and
holders of DO degrees (doctors of osteopathy) ... .In this state osteopathy is
firmly established as 'the practice of
medicine.'" The Governor noted that
DOL, in its final statement of reasons on
its proposed rulemaking, stated that the
proposed restriction ""does not prevent an
osteopathic physician from being a staff
teacher'; it applies only to the director.
Thus, the Board explicitly acknowledges
that the subject matter to be taught does
not specifically require an allopathic
orientation."

■ LEGISLATION
AB 2944 (Brulte). Existing law establishes a state medical contract program
with accredited medical schools and
programs that train, among others,
primary care physician assistants (PAs)
and primary care nurse practitioners (NPs)
to maximize the delivery of primary care
family physician services to specific areas
of California where there is a recognized
unmet priority need for these services.
Existing law requires the Health Manpower Policy Commission to establish
standards for family practice training
programs, family practice residency
programs, and programs that train primary
care PAs and primary care NPs. Existing
law further requires the Commission to
review and make recommendations to the
Director of the Office of Statewide Health
Planning and Development concerning
the funding of those programs. As
amended June 26, this bill requires the
Commission to also establish standards
for postgraduate osteopathic medical
programs in family practice. The bill also
defines "family practice" for these purposes as including the general practice of
medicine by osteopathic physicians. The
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